BRAF and thyroid cancer: Of note, PLX4720, by downregulating the expression of genes involved in tumor progression, reduced cell proliferation, migration and invasiveness of 8505c, which harbor the BRAF mutation, but not in TPC-1 (wild-type for BRAF) thyroid cancer cells [74].